Top Markets
Coin of the day
Kazia Therapeutics Limited Kazia Therapeutics Limited

Kazia Therapeutics Limited

KZA
Kedudukan dalam Saham #35840
Kazia Therapeutics Limited is a biotechnology firm specializing in oncology,... Kazia Therapeutics Limited is a biotechnology firm specializing in oncology, committed to developing innovative therapies for cancer. Its flagship product candidate, Paxalisib, is a brain-penetrant small molecule that inhibits the PI3K/Akt/mTor pathway and is currently being investigated as a potential treatment for glioblastoma. Additionally, the company is progressing EVT801, an investigational new drug aimed at combating various types of cancer. Established in 1994 and headquartered in Sydney, Australia, the entity was formerly known as Novogen Limited before adopting the name Kazia Therapeutics Limited in November 2017.
Harga Saham
$0.05207079
Disegerakkan terakhir: 2023-11-15
Modal Pasaran
$3.38M
Perubahan (1 hari)
0.13%
Perubahan (1 tahun)
0.00%
Negara
AU
Perdagangan Kazia Therapeutics Limited (KZA)

Kategori

Sejarah pecahan saham untuk Kazia Therapeutics Limited (KZA)
Saham Kazia Therapeutics Limited (simbol: KZA) telah mengalami sejumlah 0 pecahan saham.
Pecahan saham terkini berlaku pada Aug 16, 2026.
Satu saham KZA yang dibeli sebelum Aug 16, 2026 kini bersamaan dengan 0 saham KZA.
Senarai pecahan saham
Tahun Pecahan Gandaan Gandaan Kumulatif
Tidak cukup data untuk tarikh yang disediakan.
Pecahan saham untuk syarikat pesaing atau serupa
Syarikat Bilangan pecahan saham Gandaan Kumulatif Negara
1 x2
US
0 -
NL
0 -
CH
0 -
KR
0 -
BE